Cho YK, Cho JH, Hong SM, Park JH, et al. Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trial. Diabetes Obes Metab 2025 Aug 14. doi: 10.1111/dom.70030.
PMID: 40808546